CAMBRIDGE, MA, July 16, 2025 /24-7PressRelease/ -- Michael J. Storek has been selected for inclusion in Marquis Who's Who. As in all Marquis Who's Who biographical volumes, individuals profiled are selected on the basis of current reference value. Factors such as position, noteworthy accomplishments, visibility, and prominence in a field are all taken into account during the selection process.

Dr. Storek has established a distinguished career in the field of immunology, with a particular focus on the complement system. As the Head of Complement Cluster at Sanofi since 2019, he has managed a team dedicated to research and development as well as the commercial aspects of the organization. His leadership has been instrumental in advancing the company's initiatives in this specialized area of medicine. Overall, he is most proud of his role in the approval of sutimlimab, a drug targeting the classical complement pathway.

Prior to his current role, Dr. Storek served as the Director and Head of Complement Technologies at AdMIRx, now known as Q32 Bio Inc., in 2019. His expertise was further enhanced during his time as a consultant from 2016 to 2018, where he provided valuable insights and guidance to various organizations within the industry.

From 2011 to 2016, Dr. Storek held the position of Associate Director at Alexion Pharmaceuticals Inc., where he contributed significantly to the company's research and development endeavors, including his work on fosdenopterin, which is now an approved medicine for a metabolic disorder. Before that, he was the Senior Associate Director of research at Taligen Therapeutics, now part of Alexion Pharmaceuticals Inc., for one year. His journey with this firm began in 2009 as an Associate Scientific Director of protein engineering.

Dr. Storek's academic background is equally impressive, having earned a doctorate in Chemical Biology from Harvard University. He also holds a master's degree and a bachelor's degree in biochemistry and chemistry, respectively, from Charles University in Prague, which he completed before coming to the United States.

Beyond his professional pursuits, Dr. Storek is actively involved with civic-minded organizations, such as World Vision Inc., where he is a supporter. Additionally, he supports several cultural events in the Czech Republic. He is also interested in the history, art, and philosophy of the French Enlightenment, with a particular focus on Jean Jacques Rousseau.

Throughout his career, Dr. Storek has been supported by excellent mentors, dedicated colleagues, and close friends, whom he credits for his professional accomplishments. His membership in the International Complement Society has further allowed him to stay at the forefront of advancements in his field. Looking ahead, he intends to develop new medicines, continuing to make significant contributions to the healthcare industry and patient outcomes worldwide.

About Marquis Who's Who®:
Since 1899, when A. N. Marquis printed the First Edition of Who's Who in America®, Marquis Who's Who® has chronicled the lives of the most accomplished individuals and innovators from every significant field of endeavor, including politics, business, medicine, law, education, art, religion and entertainment. Who's Who in America® remains an essential biographical source for thousands of researchers, journalists, librarians and executive search firms around the world. The suite of Marquis® publications can be viewed at the official Marquis Who's Who® website, www.marquiswhoswho.com.

# # #